Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
39
PMEDF Quote, Financials, Valuation and Earnings
Last price:
$0.0500
Seasonality move
:
-22.54%
Day range:
$0.0500 - $0.0500
52-week range:
$0.0053 - $0.0670
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
116.89x
P/B ratio:
35.94x
Volume:
10K
Avg. volume:
19.4K
1-year change:
455.56%
Market cap:
$10.3M
Revenue:
--
EPS (TTM):
-$0.00
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PMEDF
Predictmedix AI, Inc.
|
-- | -- | -- | -- | -- |
|
AXGN
Axogen, Inc.
|
$56.9M | $0.07 | 17.39% | 556.06% | $35.44 |
|
ELMD
Electromed, Inc.
|
$16.6M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$9.4M | -$0.11 | -13.8% | -1168.66% | $5.00 |
|
STXS
Stereotaxis, Inc.
|
$8.4M | -$0.06 | 43.22% | -30.79% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PMEDF
Predictmedix AI, Inc.
|
$0.0500 | -- | $10.3M | -- | $0.00 | 0% | 116.89x |
|
AXGN
Axogen, Inc.
|
$33.45 | $35.44 | $1.5B | -- | $0.00 | 0% | 7.41x |
|
ELMD
Electromed, Inc.
|
$28.46 | $36.00 | $237.4M | 30.62x | $0.00 | 0% | 3.80x |
|
IRIX
IRIDEX Corp.
|
$1.17 | -- | $20.1M | -- | $0.00 | 0% | 0.39x |
|
MYO
Myomo, Inc.
|
$0.92 | $5.00 | $35.5M | -- | $0.00 | 0% | 0.91x |
|
STXS
Stereotaxis, Inc.
|
$2.30 | $4.20 | $214.6M | -- | $0.00 | 0% | 6.78x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PMEDF
Predictmedix AI, Inc.
|
-- | -2.089 | -- | 0.24x |
|
AXGN
Axogen, Inc.
|
35.99% | -0.858 | 8.25% | 2.56x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PMEDF
Predictmedix AI, Inc.
|
-$3.6K | -$222.4K | -- | -- | -- | -$17.7K |
|
AXGN
Axogen, Inc.
|
$46M | $1.9M | -1.19% | -1.94% | 3.18% | $1.4M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
Predictmedix AI, Inc. vs. Competitors
-
Which has Higher Returns PMEDF or AXGN?
Axogen, Inc. has a net margin of -- compared to Predictmedix AI, Inc.'s net margin of 1.18%. Predictmedix AI, Inc.'s return on equity of -- beat Axogen, Inc.'s return on equity of -1.94%.
Company Gross Margin Earnings Per Share Invested Capital PMEDFPredictmedix AI, Inc.-- -$0.00 -$570.6K AXGNAxogen, Inc.76.55% $0.01 $188.7M -
What do Analysts Say About PMEDF or AXGN?
Predictmedix AI, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Axogen, Inc. has an analysts' consensus of $35.44 which suggests that it could grow by 5.96%. Given that Axogen, Inc. has higher upside potential than Predictmedix AI, Inc., analysts believe Axogen, Inc. is more attractive than Predictmedix AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PMEDFPredictmedix AI, Inc.0 0 0 AXGNAxogen, Inc.7 0 0 -
Is PMEDF or AXGN More Risky?
Predictmedix AI, Inc. has a beta of 0.811, which suggesting that the stock is 18.907% less volatile than S&P 500. In comparison Axogen, Inc. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.241%.
-
Which is a Better Dividend Stock PMEDF or AXGN?
Predictmedix AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Predictmedix AI, Inc. pays -- of its earnings as a dividend. Axogen, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PMEDF or AXGN?
Predictmedix AI, Inc. quarterly revenues are --, which are smaller than Axogen, Inc. quarterly revenues of $60.1M. Predictmedix AI, Inc.'s net income of -$222.4K is lower than Axogen, Inc.'s net income of $708K. Notably, Predictmedix AI, Inc.'s price-to-earnings ratio is -- while Axogen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Predictmedix AI, Inc. is 116.89x versus 7.41x for Axogen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMEDFPredictmedix AI, Inc.116.89x -- -- -$222.4K AXGNAxogen, Inc.7.41x -- $60.1M $708K
-
Which has Higher Returns PMEDF or ELMD?
Electromed, Inc. has a net margin of -- compared to Predictmedix AI, Inc.'s net margin of 12.65%. Predictmedix AI, Inc.'s return on equity of -- beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital PMEDFPredictmedix AI, Inc.-- -$0.00 -$570.6K ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About PMEDF or ELMD?
Predictmedix AI, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 26.49%. Given that Electromed, Inc. has higher upside potential than Predictmedix AI, Inc., analysts believe Electromed, Inc. is more attractive than Predictmedix AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PMEDFPredictmedix AI, Inc.0 0 0 ELMDElectromed, Inc.4 0 0 -
Is PMEDF or ELMD More Risky?
Predictmedix AI, Inc. has a beta of 0.811, which suggesting that the stock is 18.907% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock PMEDF or ELMD?
Predictmedix AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Predictmedix AI, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PMEDF or ELMD?
Predictmedix AI, Inc. quarterly revenues are --, which are smaller than Electromed, Inc. quarterly revenues of $16.9M. Predictmedix AI, Inc.'s net income of -$222.4K is lower than Electromed, Inc.'s net income of $2.1M. Notably, Predictmedix AI, Inc.'s price-to-earnings ratio is -- while Electromed, Inc.'s PE ratio is 30.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Predictmedix AI, Inc. is 116.89x versus 3.80x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMEDFPredictmedix AI, Inc.116.89x -- -- -$222.4K ELMDElectromed, Inc.3.80x 30.62x $16.9M $2.1M
-
Which has Higher Returns PMEDF or IRIX?
IRIDEX Corp. has a net margin of -- compared to Predictmedix AI, Inc.'s net margin of -12.6%. Predictmedix AI, Inc.'s return on equity of -- beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital PMEDFPredictmedix AI, Inc.-- -$0.00 -$570.6K IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About PMEDF or IRIX?
Predictmedix AI, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 70.94%. Given that IRIDEX Corp. has higher upside potential than Predictmedix AI, Inc., analysts believe IRIDEX Corp. is more attractive than Predictmedix AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PMEDFPredictmedix AI, Inc.0 0 0 IRIXIRIDEX Corp.0 0 0 -
Is PMEDF or IRIX More Risky?
Predictmedix AI, Inc. has a beta of 0.811, which suggesting that the stock is 18.907% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock PMEDF or IRIX?
Predictmedix AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Predictmedix AI, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PMEDF or IRIX?
Predictmedix AI, Inc. quarterly revenues are --, which are smaller than IRIDEX Corp. quarterly revenues of $12.5M. Predictmedix AI, Inc.'s net income of -$222.4K is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Predictmedix AI, Inc.'s price-to-earnings ratio is -- while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Predictmedix AI, Inc. is 116.89x versus 0.39x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMEDFPredictmedix AI, Inc.116.89x -- -- -$222.4K IRIXIRIDEX Corp.0.39x -- $12.5M -$1.6M
-
Which has Higher Returns PMEDF or MYO?
Myomo, Inc. has a net margin of -- compared to Predictmedix AI, Inc.'s net margin of -36.3%. Predictmedix AI, Inc.'s return on equity of -- beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital PMEDFPredictmedix AI, Inc.-- -$0.00 -$570.6K MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About PMEDF or MYO?
Predictmedix AI, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 441.54%. Given that Myomo, Inc. has higher upside potential than Predictmedix AI, Inc., analysts believe Myomo, Inc. is more attractive than Predictmedix AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PMEDFPredictmedix AI, Inc.0 0 0 MYOMyomo, Inc.4 0 0 -
Is PMEDF or MYO More Risky?
Predictmedix AI, Inc. has a beta of 0.811, which suggesting that the stock is 18.907% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock PMEDF or MYO?
Predictmedix AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Predictmedix AI, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PMEDF or MYO?
Predictmedix AI, Inc. quarterly revenues are --, which are smaller than Myomo, Inc. quarterly revenues of $10.1M. Predictmedix AI, Inc.'s net income of -$222.4K is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Predictmedix AI, Inc.'s price-to-earnings ratio is -- while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Predictmedix AI, Inc. is 116.89x versus 0.91x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMEDFPredictmedix AI, Inc.116.89x -- -- -$222.4K MYOMyomo, Inc.0.91x -- $10.1M -$3.7M
-
Which has Higher Returns PMEDF or STXS?
Stereotaxis, Inc. has a net margin of -- compared to Predictmedix AI, Inc.'s net margin of -86.59%. Predictmedix AI, Inc.'s return on equity of -- beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital PMEDFPredictmedix AI, Inc.-- -$0.00 -$570.6K STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About PMEDF or STXS?
Predictmedix AI, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 82.61%. Given that Stereotaxis, Inc. has higher upside potential than Predictmedix AI, Inc., analysts believe Stereotaxis, Inc. is more attractive than Predictmedix AI, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PMEDFPredictmedix AI, Inc.0 0 0 STXSStereotaxis, Inc.3 0 0 -
Is PMEDF or STXS More Risky?
Predictmedix AI, Inc. has a beta of 0.811, which suggesting that the stock is 18.907% less volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock PMEDF or STXS?
Predictmedix AI, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Predictmedix AI, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PMEDF or STXS?
Predictmedix AI, Inc. quarterly revenues are --, which are smaller than Stereotaxis, Inc. quarterly revenues of $7.5M. Predictmedix AI, Inc.'s net income of -$222.4K is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, Predictmedix AI, Inc.'s price-to-earnings ratio is -- while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Predictmedix AI, Inc. is 116.89x versus 6.78x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PMEDFPredictmedix AI, Inc.116.89x -- -- -$222.4K STXSStereotaxis, Inc.6.78x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
